Literature DB >> 27870773

Tofacitinib Response in Juvenile Idiopathic Arthritis (JIA) and Collagenous Colitis.

Bryon Tseng1, Arash Amighi, Kara Bradford, Hanlin L Wang, Terri E Getzug, Ernest Brahn.   

Abstract

Entities:  

Year:  2016        PMID： 27870773     DOI： 10.1097/RHU.0000000000000456

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  2 in total

Review 1.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-11-06       Impact factor: 84.694

2.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-12-28       Impact factor: 84.694
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.